TSB-9-W1 / Taiwan Sunpan Biotech - LARVOL DELTA

To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC. (clinicaltrials.gov) - P1; N=21; Completed; Sponsor: Taiwan Sunpan Biotechnology Development Co., Ltd.; Suspended ➔ Completed; N=12 ➔ 21; Trial completion date: Dec 2018 ➔ Aug 2020; Trial primary completion date: Dec 2018 ➔ Feb 2020

Clinical • Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Colorectal Adenocarcinoma • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor